The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis. - Susin-Calle S; Munteis E; Villoslada P; Martinez-Rodriguez JE (BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2025)